In another study, compared to the control group, GHK treatment groups (1 or 10 mg/kg) demonstrated decreased neuronal apoptosis and neurological deficits in rat brains induced by intracerebral hemorrhage (ICH) injury
Even though the molecular mechanisms underlying the therapeutic potential of JS-K remain unresolved, GSTs are definitely potent activators of NO release from the compound as also demonstrated in numerous prior studies
These products are not approved for medical, diagnostic, or therapeutic use, and no instructions for preparation, administration, or dosage are provided
Some researchers notice nothing significant initially
However, benefits vary from person to person, and results are not permanent
Human MTHFR consists of an N-terminal catalytic domain (amino acids 1356) which binds 5,10-methylenetetrahydrofolate (5,10-methylene THF), and a C-terminal regulatory domain (amino acids 363656) which binds S-adenosylmethionine (AdoMet, SAM) 16,17